S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Stoke Therapeutics (STOK) News Today

$12.05
+0.40 (+3.43%)
(As of 04/19/2024 ET)
SourceHeadline
yahoo.com logoStoke-on-Trent to host its first comedy festival
yahoo.com - April 19 at 8:27 AM
msn.com logoStoke City predicted starting XI vs Plymouth as Steven Schumacher weighs up old boys' claims
msn.com - April 19 at 8:27 AM
msn.com logoProtest outside Stoke-on-Trent Crown Court - here's why
msn.com - April 19 at 8:27 AM
insidertrades.com logoStoke Therapeutics, Inc. (NASDAQ:STOK) Major Shareholder Sells $41,760,000.00 in Stock
insidertrades.com - April 19 at 6:35 AM
marketbeat.com logoStoke Therapeutics (NASDAQ:STOK) Trading 4.5% Higher
marketbeat.com - April 18 at 2:47 PM
finance.yahoo.com logoStoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
finance.yahoo.com - April 17 at 8:40 AM
businesswire.com logoStoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
businesswire.com - April 17 at 8:00 AM
msn.com logoThe focus inside the Stoke City changing room ahead of Plymouth Argyle and 'biggest game of season'
msn.com - April 17 at 1:25 AM
MarketBeat logoStoke Therapeutics, Inc. (NASDAQ:STOK) Short Interest Update
americanbankingnews.com - April 13 at 6:58 AM
MarketBeat logoStoke Therapeutics (NASDAQ:STOK) Stock Rating Reaffirmed by Needham & Company LLC
americanbankingnews.com - April 13 at 6:16 AM
MarketBeat logoStoke Therapeutics, Inc. (NASDAQ:STOK) Forecasted to Earn Q2 2024 Earnings of ($0.43) Per Share
americanbankingnews.com - April 13 at 2:16 AM
MarketBeat logoResearch Analysts Offer Predictions for Stoke Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:STOK)
americanbankingnews.com - April 13 at 1:44 AM
benzinga.com logoStoke Therapeutics Stock (NASDAQ:STOK), Analyst Ratings, Price Targets, Predictions
benzinga.com - April 12 at 9:48 AM
marketbeat.com logoQ2 2024 Earnings Forecast for Stoke Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:STOK)
marketbeat.com - April 12 at 6:24 AM
markets.businessinsider.com logoBuy Rating Justified by Stoke Therapeutics’ Promising Pipeline and Strategic Market Positioning
markets.businessinsider.com - April 12 at 12:09 AM
marketbeat.com logoStoke Therapeutics' (STOK) Buy Rating Reaffirmed at Needham & Company LLC
marketbeat.com - April 11 at 8:32 AM
marketbeat.com logoStoke Therapeutics, Inc. Forecasted to Post Q1 2024 Earnings of ($0.54) Per Share (NASDAQ:STOK)
marketbeat.com - April 11 at 7:26 AM
marketbeat.com logoStoke Therapeutics, Inc. (NASDAQ:STOK) Receives Consensus Recommendation of "Moderate Buy" from Analysts
marketbeat.com - April 6 at 2:43 AM
businesswire.com logoStoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
businesswire.com - April 4 at 4:30 PM
marketbeat.com logoStoke Therapeutics (NASDAQ:STOK) Shares Up 5.1%
marketbeat.com - April 4 at 2:24 PM
markets.businessinsider.com logoAssessing Stoke Therapeutics: Insights From 6 Financial Analysts
markets.businessinsider.com - April 4 at 2:16 PM
marketbeat.com logoStoke Therapeutics (NASDAQ:STOK) Rating Reiterated by Cantor Fitzgerald
marketbeat.com - April 4 at 10:16 AM
seekingalpha.com logoStoke Therapeutics: Positive Dravet Data Sends Shares Soaring, One For The Watchlist
seekingalpha.com - April 4 at 1:43 AM
markets.businessinsider.com logoStrong Buy Rating for Stoke Therapeutics’ STK-001 Backed by Positive KOL Feedback and Revolutionary Potential in Dravet Syndrome Treatment
markets.businessinsider.com - April 3 at 10:41 AM
marketbeat.com logoStoke Therapeutics (NASDAQ:STOK) Stock Price Down 9% After Insider Selling
marketbeat.com - April 2 at 10:27 AM
insidertrades.com logoStoke Therapeutics, Inc. (NASDAQ:STOK) General Counsel Sells $67,663.20 in Stock
insidertrades.com - April 2 at 4:26 AM
marketbeat.com logoStoke Therapeutics (NASDAQ:STOK) Shares Gap Down to $13.50
marketbeat.com - April 1 at 2:00 PM
msn.com logoStoke Stock (NASDAQ:STOK) Gains on Drug Update; Is There More Upside Left?
msn.com - April 1 at 8:27 AM
marketbeat.com logoQ1 2024 Earnings Estimate for Stoke Therapeutics, Inc. (NASDAQ:STOK) Issued By HC Wainwright
marketbeat.com - March 28 at 8:21 AM
businesswire.com logoStoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
businesswire.com - March 27 at 11:40 PM
markets.businessinsider.com logoStoke Therapeutics’ STK-001 Shows Promise: Buy Rating Affirmed Amid Positive Clinical and Financial Outlook
markets.businessinsider.com - March 27 at 2:39 PM
marketwatch.com logoStoke Therapeutics Shares Extend Gains to 52-Week High, Plans for $75M Offering
marketwatch.com - March 27 at 2:39 PM
bizjournals.com logoStoke Therapeutics plans $75M public offering on heels of Dravet trial results
bizjournals.com - March 27 at 2:39 PM
marketbeat.com logoStoke Therapeutics (NASDAQ:STOK) Reaches New 12-Month High After Analyst Upgrade
marketbeat.com - March 27 at 10:33 AM
msn.com logoWhat's Going On With Stoke Therapeutics Stock Tuesday?
msn.com - March 27 at 9:38 AM
msn.com logoShares in Bedford-based Stoke Therapeutics surge after encouraging results in studies of epilepsy medicine
msn.com - March 27 at 9:38 AM
businesswire.com logoStoke Therapeutics Announces Proposed Public Offering
businesswire.com - March 26 at 4:07 PM
msn.com logoTD Cowen ups Stoke to buy on updated data for epilepsy drug
msn.com - March 26 at 12:36 PM
msn.com logoStoke stock rockets 73% on updated epilepsy drug data
msn.com - March 26 at 12:36 PM
finance.yahoo.com logoStoke Therapeutics' Anti-Epilepsy Drug Candidate Shows Substantial, Sustained Reductions In Seizure Frequency In Pretreated Patients
finance.yahoo.com - March 26 at 12:36 PM
marketbeat.com logoWedbush Boosts Stoke Therapeutics (NASDAQ:STOK) Price Target to $17.00
marketbeat.com - March 26 at 10:46 AM
marketbeat.com logoStoke Therapeutics (NASDAQ:STOK) Stock Rating Reaffirmed by HC Wainwright
marketbeat.com - March 26 at 8:43 AM
marketbeat.com logoStoke Therapeutics (NASDAQ:STOK) Stock Rating Upgraded by TD Cowen
marketbeat.com - March 26 at 8:43 AM
investorplace.com logoWhy Is Stoke Therapeutics (STOK) Stock Up 99% Today?
investorplace.com - March 26 at 7:54 AM
investorplace.com logoSTOK Stock Earnings: Stoke Therapeutics Beats EPS, Misses Revenue for Q4 2023
investorplace.com - March 25 at 10:03 PM
msn.com logoStoke stock soars 70% post-market on epilepsy drug data
msn.com - March 25 at 7:21 PM
businesswire.com logoStoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
businesswire.com - March 25 at 4:01 PM
businesswire.com logoStoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome
businesswire.com - March 25 at 4:01 PM
investing.com logoStoke therapeutics executive sells over $14k in company stock
investing.com - March 21 at 7:33 PM
insidertrades.com logoInsider Selling: Stoke Therapeutics, Inc. (NASDAQ:STOK) General Counsel Sells 2,349 Shares of Stock
insidertrades.com - March 20 at 7:48 AM
Get Stoke Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STOK and its competitors with MarketBeat's FREE daily newsletter.

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here. 

STOK Media Mentions By Week

STOK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

STOK
News Sentiment

0.57

0.51

Average
Medical
News Sentiment

STOK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

STOK Articles
This Week

16

4

STOK Articles
Average Week

Get Stoke Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STOK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:STOK) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners